IL156662A0 - Oxazolidinone derivatives, process for the preparation thereof and pharmaceutical compositions containing the same - Google Patents
Oxazolidinone derivatives, process for the preparation thereof and pharmaceutical compositions containing the sameInfo
- Publication number
- IL156662A0 IL156662A0 IL15666201A IL15666201A IL156662A0 IL 156662 A0 IL156662 A0 IL 156662A0 IL 15666201 A IL15666201 A IL 15666201A IL 15666201 A IL15666201 A IL 15666201A IL 156662 A0 IL156662 A0 IL 156662A0
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- same
- pharmaceutical compositions
- compositions containing
- oxazolidinone derivatives
- Prior art date
Links
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical class O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1124MA2000 | 2000-12-26 | ||
| IN15MA2001 | 2001-01-15 | ||
| PCT/IN2001/000227 WO2002051819A2 (en) | 2000-12-26 | 2001-12-26 | Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL156662A0 true IL156662A0 (en) | 2004-01-04 |
Family
ID=26324889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15666201A IL156662A0 (en) | 2000-12-26 | 2001-12-26 | Oxazolidinone derivatives, process for the preparation thereof and pharmaceutical compositions containing the same |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US7030148B2 (et) |
| EP (1) | EP1345913A2 (et) |
| JP (1) | JP2004525876A (et) |
| KR (1) | KR20030063472A (et) |
| CN (1) | CN1656083A (et) |
| BG (1) | BG108022A (et) |
| BR (1) | BR0116571A (et) |
| CA (1) | CA2433138A1 (et) |
| CZ (1) | CZ20031799A3 (et) |
| EE (1) | EE200300254A (et) |
| HR (1) | HRP20030522A2 (et) |
| HU (1) | HUP0302580A2 (et) |
| IL (1) | IL156662A0 (et) |
| MX (1) | MXPA03005822A (et) |
| NO (1) | NO20032926L (et) |
| NZ (1) | NZ526716A (et) |
| PL (1) | PL363616A1 (et) |
| RU (1) | RU2322444C2 (et) |
| SK (1) | SK8202003A3 (et) |
| WO (1) | WO2002051819A2 (et) |
| YU (1) | YU52403A (et) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002329393B2 (en) | 2001-09-11 | 2008-06-12 | Astrazeneca Ab | Oxazolidinone and/or isoxazoline as antibacterial agents |
| US20060293315A1 (en) * | 2001-12-21 | 2006-12-28 | Dr. Reddy's Laboratories Ltd. | Intermediates of novel heterocyclic compounds having antibacterial activity and process for their preparation |
| US6914058B2 (en) * | 2002-01-18 | 2005-07-05 | Dr. Reddy's Laboratories, Limited | Antibacterial compounds: process for their preparation and pharmaceutical compositions containing them |
| DE10233817A1 (de) * | 2002-07-25 | 2004-02-12 | Aventis Pharma Deutschland Gmbh | Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| US7141561B2 (en) | 2002-07-25 | 2006-11-28 | Sanofi-Aventis Deutschland Gmbh | Substituted diaryl heterocycles, process for their preparation and their use as medicaments |
| WO2004089944A1 (en) * | 2003-04-07 | 2004-10-21 | Ranbaxy Laboratories Limited | Oxazolidinone derivatives as antimicrobials |
| EP1646629B1 (en) | 2003-07-02 | 2010-06-23 | Merck Sharp & Dohme Corp. | Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| US20070185132A1 (en) * | 2003-07-02 | 2007-08-09 | Yasumichi Fukuda | Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereo |
| WO2005035528A2 (en) * | 2003-10-14 | 2005-04-21 | Dr. Reddy's Laboratories Ltd. | Triazole derivatives as antibacterial agents |
| KR100854211B1 (ko) | 2003-12-18 | 2008-08-26 | 동아제약주식회사 | 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물 |
| CA2602073A1 (en) * | 2005-02-24 | 2006-08-31 | Teva Pharmaceutical Industries Ltd. | Processes for the preparation of linezolid intermediate |
| PL1928454T3 (pl) | 2005-05-10 | 2015-03-31 | Intermune Inc | Pochodne pirydonu do modulowania układu kinazy białkowej aktywowanego stresem |
| US8178683B2 (en) * | 2007-08-06 | 2012-05-15 | Micurx Pharmaceuticals, Inc. | Antimicrobial ortho-fluorophenyl oxazolidinones for treatment of bacterial infections |
| CA3034994A1 (en) | 2008-06-03 | 2009-12-10 | Intermune, Inc. | Substituted aryl-2 pyridone compounds and use thereof for treating inflammatory and fibrotic disorders |
| EP2326631A4 (en) * | 2008-08-18 | 2012-03-21 | Univ Yale | MODULATORS OF MIF |
| US9643922B2 (en) | 2008-08-18 | 2017-05-09 | Yale University | MIF modulators |
| US9540322B2 (en) | 2008-08-18 | 2017-01-10 | Yale University | MIF modulators |
| US8426389B2 (en) | 2009-02-03 | 2013-04-23 | Trius Therapeutics, Inc. | Crystalline form of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate |
| CN101798302B (zh) * | 2009-02-06 | 2014-11-05 | 上海盟科药业有限公司 | 抗生素类药物1-(邻-氟苯基)二氢吡啶酮的合成及生产的方法和工艺 |
| WO2014045292A1 (en) * | 2012-09-20 | 2014-03-27 | Symed Labs Limited | Improved process for the preparation of linezolid intermediate |
| AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
| EP3107923B1 (en) | 2014-02-21 | 2021-11-03 | Shanghai MicuRx Pharmaceutical Co., Ltd. | Water-soluble o-carbonyl phosphoramidate prodrugs for therapeutic administration |
| KR102373700B1 (ko) | 2014-04-02 | 2022-03-11 | 인터뮨, 인크. | 항섬유성 피리디논 |
| GB2550437B (en) * | 2016-05-20 | 2021-06-23 | Bugworks Res Inc | Heterocyclic compounds useful as anti-bacterial agents and method for production |
| WO2020021468A1 (en) | 2018-07-25 | 2020-01-30 | Cadila Healthcare Limited | Substituted oxazolidinones for the treatment of mammalian infections |
| WO2020234636A1 (en) | 2019-05-17 | 2020-11-26 | Cadila Healthcare Limited | Novel compounds for the treatment of mammalian infections |
| CN110301433A (zh) * | 2019-07-25 | 2019-10-08 | 河南精怡达生物科技有限公司 | 一种含有微量元素组合的猪精液体外常温保存剂 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2987505A (en) * | 1958-03-04 | 1961-06-06 | Gen Aniline & Film Corp | Compositions of polymeric nu-vinyl-2-oxazolidone and halogens |
| US3651079A (en) | 1968-11-25 | 1972-03-21 | Colgate Palmolive Co | 1-aryl-5-hydroxyalkyl-hydantoins |
| GB1408010A (en) | 1972-11-20 | 1975-10-01 | Geistlich Soehne Ag | Sulphamoylphenyl-imidazolidinones |
| US4174958A (en) | 1978-01-09 | 1979-11-20 | Shell Oil Company | Anilide derivative herbicides |
| FR2571364B1 (fr) | 1984-10-09 | 1987-07-17 | Oreal | Nouveau procede de preparation de nitroparaphenylenediamines n,n'-disubstituees, nouvelles oxazolidones utilisees dans ce procede, nouvelles nitroparaphenylenediamines n,n'-disubstituees obtenues selon ce procede et compositions tinctoriales contenant les nitroparaphenylenediamines n,n'-disubstituees obtenues selon ledit procede |
| MY115155A (en) | 1993-09-09 | 2003-04-30 | Upjohn Co | Substituted oxazine and thiazine oxazolidinone antimicrobials. |
| RU2134692C1 (ru) | 1994-10-26 | 1999-08-20 | Фармация Энд Апджон Компани | Антимикробные фенилоксазолидиноны |
| US6124334A (en) | 1995-02-03 | 2000-09-26 | Pharmacia & Upjohn Company | Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials |
| GB9601666D0 (en) | 1996-01-27 | 1996-03-27 | Zeneca Ltd | Chemical compounds |
| US6087496A (en) * | 1998-05-22 | 2000-07-11 | G. D. Searle & Co. | Substituted pyrazoles suitable as p38 kinase inhibitors |
| JPH11322729A (ja) * | 1998-03-09 | 1999-11-24 | Hokuriku Seiyaku Co Ltd | ジチオカルバミド酸誘導体 |
| JP2003513885A (ja) | 1999-07-28 | 2003-04-15 | ファルマシア・アンド・アップジョン・カンパニー | オキサゾリジノンおよび抗感染薬としてのその使用 |
| GB0118407D0 (en) | 2001-07-27 | 2001-09-19 | Cipla Ltd | Oxazolidinone derivatives as antibacterial agents |
-
2001
- 2001-11-26 YU YU52403A patent/YU52403A/sh unknown
- 2001-12-21 US US10/032,392 patent/US7030148B2/en not_active Expired - Fee Related
- 2001-12-26 CZ CZ20031799A patent/CZ20031799A3/cs unknown
- 2001-12-26 CA CA002433138A patent/CA2433138A1/en not_active Abandoned
- 2001-12-26 EP EP01995805A patent/EP1345913A2/en not_active Withdrawn
- 2001-12-26 JP JP2002552914A patent/JP2004525876A/ja not_active Withdrawn
- 2001-12-26 MX MXPA03005822A patent/MXPA03005822A/es not_active Application Discontinuation
- 2001-12-26 KR KR10-2003-7008637A patent/KR20030063472A/ko not_active Application Discontinuation
- 2001-12-26 PL PL01363616A patent/PL363616A1/xx not_active Application Discontinuation
- 2001-12-26 EE EEP200300254A patent/EE200300254A/et unknown
- 2001-12-26 CN CNA018224210A patent/CN1656083A/zh active Pending
- 2001-12-26 WO PCT/IN2001/000227 patent/WO2002051819A2/en active IP Right Grant
- 2001-12-26 HU HU0302580A patent/HUP0302580A2/hu unknown
- 2001-12-26 SK SK820-2003A patent/SK8202003A3/sk not_active Application Discontinuation
- 2001-12-26 NZ NZ526716A patent/NZ526716A/en unknown
- 2001-12-26 BR BR0116571-2A patent/BR0116571A/pt not_active IP Right Cessation
- 2001-12-26 IL IL15666201A patent/IL156662A0/xx unknown
- 2001-12-26 RU RU2003123104/04A patent/RU2322444C2/ru not_active IP Right Cessation
-
2003
- 2003-06-25 NO NO20032926A patent/NO20032926L/no unknown
- 2003-06-26 HR HR20030522A patent/HRP20030522A2/hr not_active Application Discontinuation
- 2003-07-22 BG BG108022A patent/BG108022A/bg unknown
- 2003-08-01 US US10/632,950 patent/US7183301B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002051819A9 (en) | 2003-08-07 |
| US20040059120A1 (en) | 2004-03-25 |
| WO2002051819A2 (en) | 2002-07-04 |
| US20030065175A1 (en) | 2003-04-03 |
| CZ20031799A3 (cs) | 2004-02-18 |
| EE200300254A (et) | 2003-12-15 |
| NO20032926L (no) | 2003-08-25 |
| NO20032926D0 (no) | 2003-06-25 |
| HUP0302580A2 (hu) | 2003-11-28 |
| CA2433138A1 (en) | 2002-07-04 |
| US7183301B2 (en) | 2007-02-27 |
| BG108022A (bg) | 2004-09-30 |
| JP2004525876A (ja) | 2004-08-26 |
| NZ526716A (en) | 2005-08-26 |
| RU2003123104A (ru) | 2005-03-10 |
| RU2322444C2 (ru) | 2008-04-20 |
| CN1656083A (zh) | 2005-08-17 |
| YU52403A (sh) | 2006-03-03 |
| PL363616A1 (en) | 2004-11-29 |
| MXPA03005822A (es) | 2004-05-04 |
| SK8202003A3 (en) | 2004-07-07 |
| WO2002051819A3 (en) | 2002-12-05 |
| KR20030063472A (ko) | 2003-07-28 |
| EP1345913A2 (en) | 2003-09-24 |
| HRP20030522A2 (en) | 2005-06-30 |
| BR0116571A (pt) | 2004-03-02 |
| US7030148B2 (en) | 2006-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL156662A0 (en) | Oxazolidinone derivatives, process for the preparation thereof and pharmaceutical compositions containing the same | |
| HUP0203902A3 (en) | Substituted oxazolidinones, process for their preparation and pharmaceutical compositions containing them and their use | |
| HUP0103082A2 (en) | Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0301315A3 (en) | Benzothiazole derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
| IL144501A0 (en) | Epothilone derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same | |
| HUP0103404A3 (en) | Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0203542A3 (en) | 3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same | |
| HUP0301069A3 (en) | Novel biarylcarboxamides, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP0303524A3 (en) | Novel quinuclidine derivatives, process for their preparation and medicinal compositions containing the same and their use | |
| HUP0300618A3 (en) | Adamantana derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
| DZ3311A1 (fr) | Compositions pharmaceutiques contenant des derives de 3-amino-azetidine, les nouveaux derives et leur preparation | |
| HUP0301187A3 (en) | Novel benzyl-piperidine-derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0204245A3 (en) | Novel n-azabicyclo-amide derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP0203766A3 (en) | 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof and pharmaceutical compositions containing them | |
| HUP0201516A3 (en) | 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0201753A2 (en) | Pyridopyranoazepine derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0303118A3 (en) | Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them | |
| IL154096A0 (en) | Aporphine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| HUP0203597A3 (en) | Pharmaceutical compositions containing zolmitriptan, process for their preparation and their use | |
| HUP0201402A3 (en) | Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them | |
| HUP9803040A3 (en) | Thiazole derivatives, process for the preparation thereof, use thereof and pharmaceutical compositions containing them | |
| HUP0201315A3 (en) | 4-phenyl-pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
| HUP0302515A3 (en) | Sulfanidothienopyrimidines, process for their preparation and pharmaceutical compositions containing them | |
| HUP0303361A3 (en) | Substituted 1-aminobutan-3-ol derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0204001A3 (en) | Substituted aminomethyl-phenyl-cyclohexane derivatives, process for their preparation and pharmaceutical compositions containing them |